1.12
-0.04 (-3.45%)
-0.04 (-3.45%)
Upgrade to Real-Time
Afterhours
Volume | 482,765 |
|
|||||
News | - | ||||||
Day High | 1.18 | Low High |
|||||
Day Low | 1.11 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Outlook Therapeutics Inc | OTLK | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.16 | 1.11 | 1.18 | 1.17 | 1.16 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
2,108 | 482,765 | $ 1.15 | $ 553,999 | - | 0.6839 - 2.12 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:44:34 | 10 | $ 1.19 | USD |
Outlook Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 287.47M | 256.67M | 180.71M | $ - | $ - | -0.31 | -3.70 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | - | 14.90M | 4.30% |
Outlook Therapeutics News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OTLK Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.09 | 1.20 | 1.08 | 1.15 | 335,400 | 0.03 | 2.75% |
1 Month | 1.04 | 1.37 | 1.01 | 1.18 | 577,260 | 0.08 | 7.69% |
3 Months | 1.07 | 1.37 | 0.80 | 1.08 | 482,570 | 0.05 | 4.67% |
6 Months | 1.12 | 1.37 | 0.80 | 1.14 | 481,363 | 0.00 | 0.0% |
1 Year | 1.40 | 2.12 | 0.6839 | 1.41 | 801,636 | -0.28 | -20.0% |
3 Years | 0.96 | 4.26 | 0.499 | 1.72 | 1,641,387 | 0.16 | 16.67% |
5 Years | 5.60 | 20.00 | 0.4011 | 1.88 | 1,608,814 | -4.48 | -80.0% |
Outlook Therapeutics Description
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. |